OmicVision Biosciences ApS
Private limited companyCVR 44285584København ØActive
OmicVision Biosciences ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2023. The company made a loss in both 2024 and 2025, most recently DKK 4.4m. With 17 employees, the company is about 3 times larger than the industry median. Equity fell to DKK 117k in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 133% (2024 → 2025), to DKK 3.6m.
- The loss grew: from DKK 3m to DKK 4.4m (2024 → 2025).
- Equity fell 97% (2024 → 2025), to DKK 117k.
Employees
- 7 more employees than a year earlier: 17 (07/2026) against 10 (07/2025).
Registrations, last 24 months
- 08/06/2026: Moved to Ryesgade 113, 2100 København Ø
- 04/05/2026: Share capital changed from 50,000 DKK to 51,000 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | 1,538 | 3,582 | +133% |
| Operating profit (EBIT) | −3,544 | −4,467 | −26% |
| Profit before tax | −3,431 | −4,416 | −28.7% |
| Net profit | −3,007 | −4,416 | −46.9% |
| Total assets | 5,486 | 12,342 | +125% |
| Equity | 4,533 | 117 | −97.4% |
| Liabilities | 953 | 12,225 | +1,183.3% |
| Cash and cash equivalents | 605 | 5,421 | +795.8% |
| Average number of employees | 4 | 9 | +125% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 97% from 2024 to 2025 (DKK 4.5m to DKK 117k).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
Low equity ratio
Equity makes up 1% of total assets in 2025.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 13/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/09/2023 – 31/12/2024 | 26/06/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 19,178of 69,742 Better than 73% | No. 53,983of 69,964 Better than 23% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 64of 323 Better than 80% | No. 200of 329 Better than 39% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 3,287of 16,614 Better than 80% | No. 9,876of 16,661 Better than 41% |
| All companies of type ApS66,508 companies in the comparison | No. 19,115of 66,379 Better than 71% | No. 50,138of 66,505 Better than 25% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- OmicVision Biosciences ApSDKK 3.6m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- OmicVision Biosciences ApS−DKK 4.4m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- OmicVision Biosciences ApSDKK 117k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- OmicVision Biosciences ApS17
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Voma Holding A/S33.33%
- AM Tech Ventures ApS15%
- MS Ventures ApS15%
- Ummat Ventures ApS10%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Andreas Mund | Director | 01/09/2023 |
| Maximilian Thomas Dr Strauss | Director | 01/09/2023 |
| Ishani Tara Ummat | CEO | 01/05/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Ole Vorm | Chair of the board | 01/12/2023 |
| Andreas Mund | Board member | 01/12/2023 |
| Maximilian Thomas Dr Strauss | Board member | 01/12/2023 |
- Founders
- AM Tech Ventures ApS, MS Ventures ApS
Signing rule: Selskabet tegnes af en direktør i forening med bestyrelsesformanden.
Address and production units
1 active production unitsRyesgade 113
2100 København Ø
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Resolute Bio | Ryesgade 113, 2100 København Ø | 17 | 1032226821 |
Purpose
Selskabets formål er at drive bioteknologisk forskning og udvikling af diagnostik til kræft og andre sygdomme, samt hermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
28 registered events20263 changesaddress 1 · accounts 1 · capital 1
- AddressMoved to Ryesgade 113, 2100 København Ø
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 50,000 DKK to 51,000 DKK
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20249 changesaddress 1 · ownership 7 · management 1
- AddressMoved to Ole Maaløes Vej 3, 1, 2200 København N
- OwnershipMS Ventures ApS registered as owner (15%)
- OwnershipVOMA HOLDING A/S registered as owner (33.33%)
- OwnershipAM Tech Ventures ApS registered as owner (15%)
- OwnershipUmmat Ventures ApS registered as owner (10%)
- OwnershipMS Ventures ApS is no longer registered as owner
- OwnershipVOMA HOLDING A/S is no longer registered as owner
- OwnershipAM Tech Ventures ApS is no longer registered as owner
- ManagementIshani Tara Ummat appointed ceo
202314 changescapital 1 · management 5 · ownership 7 · founded 1
- CapitalShare capital changed from 40,000 DKK to 50,000 DKK
- ManagementOle Vorm appointed chair of the board
- ManagementAndreas Mund appointed board member
- ManagementMaximilian Thomas Dr Strauss appointed board member
- OwnershipMS Ventures ApS registered as owner (20%)
- OwnershipVOMA HOLDING A/S registered as owner (50%)
- OwnershipAM Tech Ventures ApS registered as owner (20%)
- OwnershipAM Tech Ventures ApS is no longer registered as owner
- OwnershipMS Ventures ApS is no longer registered as owner
- FoundedRegistered as OmicVision Biosciences ApS
- ManagementAndreas Mund appointed director
- ManagementMaximilian Thomas Dr Strauss appointed director
- OwnershipAM Tech Ventures ApS registered as owner (50%)
- OwnershipMS Ventures ApS registered as owner (50%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Evosep ApSvia Ole Vorm
- Fida Biosystems ApSvia Ole Vorm
- Spectro Inlets ApSvia Ole Vorm
- Proximus A/Svia Ole Vorm
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.